State of the Art: Concise ReviewProgrammed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art?
Under an Elsevier user license
open archive
Key Words
Immune check-point inhibitors
PD-1
PD-L1
Immunohistochemistry
Biomarker assay
Cited by (0)
Disclosure: The authors declare no conflict of interest.
Copyright © 2015 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.